Justin W. Chairman
+1.215.963.5061
justin.chairman@morganlewis.com
October 12, 2023
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Perry Hindin, Esquire
| Re: | MEI Pharma, Inc. |
Preliminary Consent Revocation Statement on Schedule 14A filed September 15, 2023
File No. 000-50484
To Whom it May Concern:
On behalf of MEI Pharma, Inc. (the “Company”), we submit this letter to notify the Staff of the Company’s filing of a revised Preliminary Consent Revocation Statement on Schedule 14A. This filing is being made in response to the filing on October 10, 2023, by Cable Car Capital LLC, Anson Advisors Inc. and the other participants named therein, of a Definitive Consent Statement on Schedule 14A.
* * * *
If you have any questions or comments or require any additional information, please do not hesitate to contact me at +1.215.963.5061 or Bryan S. Keighery at +1.617.341.7269.
| Very truly yours,
/s/ Justin W. Chairman |
cc: David M. Urso
| Morgan, Lewis & Bockius LLP | ||||
| 1701 Market St. | ||||
| Philadelphia, PA 19103-2921 United States |
| |||
+1.215.963.5000
+1.215.963.5001